Safety of perioperative treatment with biologics in patients with inflammatory bowel disease undergoing bowel surgery: Experience from a large urban center.

Fabian SchnitzlerCornelia Tillack-SchreiberDaniel SzokodiIsabel BraunJune TomeldenMaximilian SohnFranz BaderConstanze Heike WaggershauserThomas Ochsenkühn

Published in: PloS one (2024)

This retrospective single center study of 447 IBD patients goes to demonstrate that perioperative use of biologics is not associated with a higher risk of complications.

Keyphrases

patients with inflammatory bowel disease
end stage renal disease
cardiac surgery
patients undergoing
minimally invasive
chronic kidney disease
newly diagnosed
prognostic factors
coronary artery bypass
atrial fibrillation
acute coronary syndrome
combination therapy
percutaneous coronary intervention